RSNA: IBMs Watson has a future in radiology

Eliot L. Siegel, MD - 15.82 Kb
Eliot L. Siegel, MD
CHICAGO—After trouncing human intelligence on the television game show “Jeopardy” last February, IBM’s supercomputer Watson may make its way into radiology departments in the future, according to research presented by Nick van Terheyden, MD, chief medical information officer of Nuance Communications, based in Burlington, Mass., at a Nov. 29 presentation during the 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA).

van Terheyden described the process behind Watson’s artificial brainpower, dubbed DeepQA, and elaborated how the technology could impact the delivery of care. DeepQA reflects a significant advancement in artificial intelligence and could allow radiologists to retrieve pertinent clinical data that otherwise may not be available due to researching time constraints.

Watson works by analyzing an initial question and posing several chains of hypotheses based on a semantic framework of data. van Terheyden loaded massive amounts of clinical data into the supercomputer and tested the technology  by posing a number of questions related to care. For the most part, Watson was impressive.

Asked what hormone deficiency was associated with Kallmann’s syndrome, Watson answered correctly with GnRH. Several other questions were answered correctly as well. However, when asked a question about obesity hypoventilation, Watson answered incorrectly.

After the kinks are worked out, van Terheyden anticipates the technology will be useful in the care setting, particularly with the exponentially growing amounts of healthcare data. “We see this as being able to provide knowledge at the point of the radiology read,” he said.

The challenge is pulling non-standard systems together to retrieve information, many of which do not have an analog to connect to Watson, he noted. Importantly, Terheyden predicted that Watson will never replace the human doctor.

"The ideal clinician is confident, empathetic, humane," he said. "Watson is the antithesis."

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.